Related Experiment Videos
Increases in depression after cholesterol-lowering drug treatment
K W Davidson1, S Reddy, P McGrath
1Dalhousie University in Halifax, Nova Scotia.
Insights
Cholesterol-lowering interventions may increase depressive symptoms in some patients. Further research is needed to explore the link between low cholesterol, depression, and brain chemistry.
Area of Science:
- Cardiology
- Psychiatry
- Neuroscience
Background:
- Cholesterol-lowering interventions are common for cardiovascular health.
- Potential side effects of these interventions require thorough investigation.
Purpose of the Study:
- To explore the potential association between cholesterol-lowering treatments and increased depressive symptoms.
- To assess changes in depression scores in patients undergoing lipid-lowering therapy.
Main Methods:
- A cohort of 6 men referred to a lipid clinic participated.
- The Center for Epidemiological Studies-Depression (CES-D) scale was administered pre- and post-intervention.
- Cholesterol levels were monitored over a 6-week period.
Main Results:
- All patients achieved reduced cholesterol levels after the 6-week intervention.
- Four out of six patients experienced an increase in depression scores.
- Two of these four patients met criteria for mild clinical depression.
Conclusions:
- A potential link exists between cholesterol reduction and increased depressive symptoms.
- Further investigation into the relationship between low cholesterol, depression, and serotonergic activity is warranted.
Abstract:
To investigate the possibility that increases in depressive symptoms might occur in patients who have undergone cholesterol-lowering interventions, the authors administered the Center for Epidemiological Studies-Depression scale before and after cholesterol lowering to 6 men who were referred to a lipid clinic. All of the patients' cholesterol levels were reduced after the 6-week intervention, and 4 of the patients' depression scores increased; scores of 2 of the 4 met the criteria for mild clinical depression. Further study of possible links among low cholesterol, depressive symptoms, and serotonergic activity is needed.